$0.23
Value $1.8M
MRM and TSLA stock compared: price, dividend, valuation and results, from SEC filings.
$0.23
Value $1.8M
$345.82
Value $1.37T
MEDIROM Healthcare Technologies (MRM) has a market value of $1.8M and Tesla (TSLA) $1.37T. Over the last year, with dividends, MRM moved -88.9% and TSLA -14.4%.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
MRM$1.8M
TSLA$1.37T
TSLA is 752,122 times MRM
Revenue, 12 months
MRM$50M
TSLA$104B
TSLA is 2,092 times MRM
Net income, 12 months
MRM-$23M
TSLA$3.2B
Operating margin
MRM-43.7%
TSLA3.4%
47.1 points apart
ROIC
MRM–
TSLA2.9%
P/E
MRM–
TSLA424.8
Dividend yield
MRM0.0%
TSLA0.0%
About the same
5-year return
MRM-97.0%
TSLA-8.8%
88.2 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
MRM-97.0%
TSLA-8.8%
| Period | MRMWith dividends | TSLAWith dividends |
|---|---|---|
| 1 year since November 19, 2025 | -88.9%Price -88.9% | -14.4%Price -14.4% |
| 3 years since November 20, 2023 | -95.3%-63.9% a yearPrice -95.3% | +46.8%+13.6% a yearPrice +46.8% |
| 5 years since November 19, 2021 | -97.0%-50.4% a yearPrice -97.0% | -8.8%-1.8% a yearPrice -8.8% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
MRMMEDIROM Healthcare TechnologiesTSLATesla
| Price | $0.23 | $345.82 |
|---|---|---|
| Market value | $1.8M | $1.37T |
| Enterprise value (EV) | – | $1.33T |
| P/E | – | 424.8 |
| P/E, 5-year median | 21.8 | – |
| P/B | – | 15.3 |
| EV/EBIT | – | 384.0 |
| Free cash flow yield | – | 0.2% |
| Revenue, 12 months | $50M | $104B |
|---|---|---|
| Net income, 12 months | -$23M | $3.2B |
| Free cash flow, 12 months | -$7.4M | $3.3B |
| Earnings per share, 12 months | -$2.93 | $0.91 |
| Revenue growth, year on year | -6.5% | -2.9% |
| Revenue growth a year, past | +18.4%over 5 years | +24.6%over 5 years |
| EPS growth a year, past | – | +38.8%over 5 years |
| Gross margin | – | 19.3% |
|---|---|---|
| Operating margin | -43.7% | 3.4% |
| Net margin | -46.8% | 3.1% |
| ROIC | – | 2.9% |
| ROE | – | 3.8% |
| Cash | $625.9K | $45.4B |
|---|---|---|
| Total debt | – | $16.4B |
| Net debt / EBITDA | – | -4.2 |
| Interest cover | – | 10.0× |
| Dividend yield | – | – |
|---|---|---|
| Dividend per share, 12 months | – | – |
| Dividend growth a year, past | – | – |
| Buyback yield | – | – |
| Shareholder yield | – | – |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, Tesla ($1.37T) is about 752,121.9 times MEDIROM Healthcare Technologies ($1.8M), at today's prices.
Since November 19, 2021, MRM's price moved -97.0% and TSLA's -8.8%. With dividends: MRM -97.0% (-50.4% a year), TSLA -8.8% (-1.8% a year). Past returns do not predict future ones.
Neither paid a dividend over the last twelve months: MEDIROM Healthcare Technologies and Tesla return money to shareholders, if they do, in other ways, such as buybacks.
Over the last twelve months, the net margin was -46.8% for MEDIROM Healthcare Technologies and 3.1% for Tesla, and the operating margin -43.7% and 3.4%. Revenue was $50M and $104B.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.